Abstract
Memantine and cholinesterase inhibitors (ChEI) have distinct pharmacological actions, and interest in the use of combination therapy for Alzheimer's disease (AD) is increasing.
| Original language | English |
|---|---|
| Pages (from-to) | 121-125 |
| Number of pages | 5 |
| Journal | Neuropsychiatric Disease and Treatment |
| Volume | 2 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Jun 2006 |